Literature DB >> 2053791

Prevalence of liver disease in cystic fibrosis.

R Scott-Jupp1, M Lama, M S Tanner.   

Abstract

To assess the prevalence, demography, and clinical features of liver disease among patients with cystic fibrosis the case notes of 524 patients of all ages who were attending the cystic fibrosis clinic were studied. Computer databases were used to establish the condition of the liver in a further 576 such patients. The overall prevalence of overt liver disease indicated by the presence of an enlarged liver or spleen (or both) was 4.2%. The age related prevalence rose to a peak in adolescence, and then fell in patients over 20 years old. The implied increase in mortality among those with liver disease was not explained by deaths from liver disease, which were rare. Male patients were significantly more affected than female, the ratio being 3:1 among adolescents. Increasing prevalence of liver disease in patients with cystic fibrosis is, therefore, not just a result of longevity.

Entities:  

Mesh:

Year:  1991        PMID: 2053791      PMCID: PMC1793169          DOI: 10.1136/adc.66.6.698

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  23 in total

1.  Hepatic cirrhosis associated with fibrocystic disease of the pancreas; clinical and pathological reports of five patients.

Authors:  R WEBSTER; H WILLIAMS
Journal:  Arch Dis Child       Date:  1953-10       Impact factor: 3.791

2.  Liver disease and bile duct abnormalities in adults with cystic fibrosis.

Authors:  R A Nagel; D Westaby; A Javaid; J Kavani; H B Meire; M G Lombard; A Wise; R Williams; M E Hodson
Journal:  Lancet       Date:  1989-12-16       Impact factor: 79.321

3.  The effects of age on alkaline phosphatase and other serologic liver function tests in normal subjects and patients with cystic fibrosis.

Authors:  J Kattwinkel; L M Taussig; B E Statland; J I Verter
Journal:  J Pediatr       Date:  1973-02       Impact factor: 4.406

Review 4.  Cystic fibrosis: its influence on the liver, biliary tree, and bile salt metabolism.

Authors:  J N Isenberg
Journal:  Semin Liver Dis       Date:  1982-11       Impact factor: 6.115

Review 5.  Gastrointestinal manifestations of cystic fibrosis: a review.

Authors:  R W Park; R J Grand
Journal:  Gastroenterology       Date:  1981-12       Impact factor: 22.682

6.  Symptomatic hepatic disease in cystic fibrosis: incidence, course, and outcome of portal systemic hunting.

Authors:  R C Stern; D P Stevens; T F Boat; C F Doershuk; R J Izant; L W Matthews
Journal:  Gastroenterology       Date:  1976-05       Impact factor: 22.682

7.  Relation of steatosis to cirrhosis.

Authors:  H Thaler
Journal:  Clin Gastroenterol       Date:  1975-05

8.  Cystic fibrosis: ultrasonographic findings in the pancreas and hepatobiliary system correlated with clinical data and pathology.

Authors:  N Graham; A R Manhire; R J Stead; W R Lees; M E Hodson; J C Batten
Journal:  Clin Radiol       Date:  1985-03       Impact factor: 2.350

9.  Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts.

Authors:  C C Roy; A M Weber; C L Morin; G Lepage; G Brisson; I Yousef; R Lasalle
Journal:  J Pediatr Gastroenterol Nutr       Date:  1982       Impact factor: 2.839

Review 10.  Biliary lipid composition in patients with cystic fibrosis.

Authors:  M Becker; D Staab; O Leiss; K von Bergmann
Journal:  J Pediatr Gastroenterol Nutr       Date:  1989-04       Impact factor: 2.839

View more
  36 in total

1.  Liver and biliary problems in cystic fibrosis.

Authors:  M S Tanner
Journal:  J R Soc Med       Date:  1992       Impact factor: 5.344

Review 2.  The role of abdominal ultrasound in the diagnosis, staging and management of cystic fibrosis liver disease.

Authors:  Louise Stewart
Journal:  J R Soc Med       Date:  2005       Impact factor: 5.344

Review 3.  Liver disease in cystic fibrosis.

Authors:  M S Tanner; C J Taylor
Journal:  Arch Dis Child       Date:  1995-04       Impact factor: 3.791

Review 4.  Subclinical colonic thickening.

Authors:  P J Oades; M Rosenthal; E J Mac Sweeney; A Bush
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

5.  Annual review or continuous assessment?

Authors:  S B Carr; R Dinwiddie
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

6.  A prognostic model for the prediction of survival in cystic fibrosis.

Authors:  K M Hayllar; S G Williams; A E Wise; S Pouria; M Lombard; M E Hodson; D Westaby
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 7.  Liver transplantation for hepatic cirrhosis in cystic fibrosis.

Authors:  G Noble-Jamieson; N Barnes; N Jamieson; P Friend; R Calne
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

8.  Choline Supplementation With a Structured Lipid in Children With Cystic Fibrosis: A Randomized Placebo-Controlled Trial.

Authors:  Joan I Schall; Maria R Mascarenhas; Asim Maqbool; Kelly A Dougherty; Okan Elci; Dah-Jyuu Wang; Talissa A Altes; Kevin A Hommel; Walter Shaw; Jeff Moore; Virginia A Stallings
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-04       Impact factor: 2.839

9.  Partial splenectomy in cystic fibrosis patients with hypersplenism.

Authors:  G H Thalhammer; E Eber; S Uranüs; J Pfeifer; M S Zach
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

10.  Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization.

Authors:  T V Strong; K Boehm; F S Collins
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.